C. Greene (Dublin 9, Ireland), P. Palange (Rome, Italy)
Ivacaftor/lumacaftor changes the lung microbiome and metabolome in cystic fibrosis patients
A. Neerincx (Amsterdam, Netherlands), K. Whiteson (Irvine, California, United States of America), J. Phan (Irvine, California, United States of America), P. Brinkman (Amsterdam, Netherlands), M. Abdel-Aziz (Amsterdam, Netherlands), E. Weersink (Amsterdam, Netherlands), J. Altenburg (Amsterdam, Netherlands), C. Majoor (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands)
|     |
Non-contrast-enhanced assessment of lung perfusion in CF patients during respiratory tract exacerbation using Fourier decomposition magnetic resonance imaging (FDMRI)
A. Mazzaro (Treviso, Italy), M. Ros (Treviso, Italy), S. Bertolo (Treviso, Italy), P. Ciet (Rotterdam, Netherlands), F. Serafini (Padova, Italy), G. Morana (Treviso, Italy)
| |
Correlation of Hyperpolarised Xenon-129 Magnetic Resonance Imaging (129Xe-MRI) of the Lung with Multi-Breath Washout (MBW) in Children with Severe Asthma
S. Safavi (Nottingham, United Kingdom), B. Zanette (Toronto, Canada), S. Munidasa (Toronto, Canada), E. Stirrat (Toronto, Canada), D. Li (Toronto, Canada), T. Moraes (Toronto, Canada), P. Subbarao (Toronto, Canada), G. Santyr (Toronto, Canada)
| |
Interpretation of multiple breath washout (MBW) measurements of lung function using mathematical modelling and hyperpolarised 3He gas MRI
C. Whitfield (Manchester, United Kingdom), L. Smith (Sheffield, United Kingdom), O. Jensen (Manchester, United Kingdom), N. West (Sheffield, United Kingdom), M. Wildman (Sheffield, United Kingdom), G. Collier (Sheffield, United Kingdom), J. Wild (Sheffield, United Kingdom), A. Horsley (Manchester, United Kingdom)
| |
Multiple-breath washout and pulmonary function tests versus high-resolution computed tomography scores in adults with cystic fibrosis.
A. Cherniak (Moscow, Russian Federation), Z. Naumenko (Moscow, Russian Federation), S. Krasovskiy (Moscow, Russian Federation), K. Mikhailichenko (Moscow, Russian Federation), G. Nekludova (Moscow, Russian Federation)
| |
Using integrated omics to assess the effects of rhinovirus infection in children with Cystic Fibrosis (CF).
P. Agudelo-Romero (Perth (WA), Australia), K. Martinovich (Perth (WA), Australia), J. Chandler (Atlanta (GA), United States of America), K. Ling (Perth (WA), Australia), E. Sutanto (Perth (WA), Australia), D. Jones (Atlanta (GA), United States of America), R. Tirouvanzium (Atlanta (GA), United States of America), S. Stick (Perth (WA), Australia), L. Garratt (Perth (WA), Australia), A. Kicic (Perth (WA), Australia), W. Erp (Perth (WA), Australia), A. Cf (Perth (WA), Australia)
| |
Pseudomonas aeruginosa influences the inflammatory response of primary bronchial epithelial cells to rhinovirus infection
A. Endres (Frankfurt am Main, Germany), R. Schubert (Frankfurt am Main, Germany), P. Braubach (Hanover, Germany), D. Jonigk (Hanover, Germany), M. Hogardt (Frankfurt am Main, Germany), H. Boland (Frankfurt am Main, Germany), G. Rohde (Frankfurt am Main, Germany), C. Bellinghausen (Frankfurt am Main, Germany)
| |
A First Look at the Italian Registry on Pulmonary Non-Tuberculous Mycobacteria (NTM) -IRENE
S. Aliberti (Milano, Italy), M. Spotti (Milano, Italy), G. Sotgiu (Sassari, Italy), M. Ferrarese (Milano, Italy), P. Castellotti (Milano, Italy), A. Gramegna (Milano, Italy), M. Tadolini (Bologna, Italy), J. Mencarini (Firenze, Italy), G. Gualano (Roma, Italy), S. Cerri (Modena, Italy), G. Montemurro (Roma, Italy), G. Gardini (Brescia, Italy), A. Calcagno (Torino, Italy), F. Dente (Pisa, Italy), M. Trezzi (Pistoia, Italy), P. Faverio (Monza, Italy), M. Malerba (Vercelli, Italy), G. Cucchetto (Verona, Italy), E. Tortoli (Milano, Italy), M. Mirsaeidi (Miami, United States of America), A. Previdi (Milano, Italy), A. Gori (Milano, Italy), L. Codecasa (Milano, Italy), F. Blasi (Milano, Italy), .. On Behalf Of The Irene Network (Milano, Italy)
| |
A pilot study of a novel ELISA test using synthetic mycolic acid antigens for serodiagnosis of nontuberculous mycobacterial infections.
J. Bashford (Cambridge, United Kingdom), R. Floto (Cambridge, United Kingdom), C. Haworth (Cambridge, United Kingdom), J. Ryan (Cambridge, United Kingdom), J. Al Dulayymi (Wales, United Kingdom), A. Cervi (Wales, United Kingdom), M. Baird (Wales, United Kingdom)
| |
Ultrasound diaphragm activity in patients with cystic fibrosis: relationship to disease severity and peripheral muscle strength
A. Maynard (Montreal, Canada), F. Tremblay (Montreal, Canada), B. Dubé (Montreal, Canada)
| |